Woman-Diabetes-Insulin_G_645403776 Compared with human neutral protamine Hagedorn insulin, basal insulin analogs do not reduce risk of hypoglycemia-linked ED visits or hospital admissions in T2D. For ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ORLANDO -- Human ...
No reduced risk of hypoglycemia-linked ER visits, admissions for basal insulin analog vs. NPH insulin HealthDay News — Initiation of a basal insulin analog versus human neutral protamine Hagedorn (NPH ...
ORLANDO — Patients with type 2 diabetes starting insulin therapy for the first time who were prescribed a basal insulin analog, compared with human neutral protamine Hagedorn (NPH) insulin, did not ...
Dr. Marie McDonnell, the director of the Brigham Diabetes Program at Brigham and Women’s Hospital in Boston, told TODAY that basal insulin is a long-acting insulin therapy that helps the body process ...
If you’re taking basal insulin therapy, your treatment approach will be different from others with type 2 diabetes. Even if you’ve been taking this type of insulin for a long time, it’s good to remind ...
HAMBURG, Germany -- Adding weekly tirzepatide (Mounjaro) to basal insulin reduced HbA1c in patients with poorly controlled type 2 diabetes compared with adding three-times-daily insulin lispro, the ...
INDIANAPOLIS, Sept. 4, 2014 /PRNewswire/ -- Eli Lilly and Company's (NYSE: LLY) basal insulin peglispro (BIL) demonstrated a statistically significant lower hemoglobin A1c (HbA1c) compared with ...
Dr. Hirsch answers the question: 'Pros and Cons of Different Insulin Types?' — -- Question:What are the pros and cons of various types of insulins? Answer:I don't think we should think of insulin ...
Answer B: Hyperbaric oxygen treatments will often lower blood glucose values, leaving patients with diabetes at risk for hypoglycemia during these treatments. Hyperbaric oxygen treatments involve the ...
Basal Insulin Peglispro Efficacious in Type 1 Diabetes Trials Eli Lilly and Company announced results from its IMAGINE-1 and IMAGINE-3 Phase 3 trials with basal insulin peglispro (BIL) in patients ...
April 30, 2004 — Insulin determir offers improved glycemic contol compared with NPH insulin in people with type I diabetes, according to the results of a randomized trial published in the May issue of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback